ArticleMolecular therapy. Nucleic acids2022

First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, ApTOLL: Safety and pharmacokinetics in healthy volunteers.

Macarena Hernández-Jiménez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.